Levels of VEGF and Ki67 protein expression in tumor tissues from the different treatment groups were analyzed via immunohistochemistry to verify the results of transcriptome and proteome analyses in our study (Fig. 5A, B). The gene discussed is VEGFA; the disease is neoplasm.